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Development of a rabbit corneal equivalent using an acellular
corneal matrix of a porcine substrate
Yong-gen Xu, Yong-sheng Xu, Chen Huang, Yun Feng, Ying Li, Wei Wang
Department of Ophthalmology, Peking University Third Hospital, Beijing, China
Purpose: The tissue equivalent that mimics the structure and function of normal tissue is a major bioengineering challenge.
Tissue engineered replacement of diseased or damaged tissue has become a reality for some types of tissue such as skin
and cartilage. The tissue engineered corneal epithelium, stroma, and endothelium scaffold are promising concepts in
overcoming the current limitations of a cornea replacement with an allograft.
Methods: The acellular corneal matrix from porcine (ACMP) was examined as a potential corneal cell sheet frame. The
physical and mechanical properties of strength, expansion, transparency, and water content of the ACMP were measured.
The major antigens of the cell components were completely removed with series of extraction methods, the major antigens
of the cell components were identified by hematoxylin and eosin (HE), immunofluorescence staining, and scanning
electron microscopy. The structural properties were investigated by HE stain and scanning electron microscopy. The three
types of rabbit corneal cells were cultured in vitro, and characteristics were investigated by colony formation efficiency
(CFE), BrdU staining, immunofluorescence staining, and western blot assay of keratin 3 (K3), vimentin, and aquaporin
A. The biocompatibility of the ACMP was investigated for one month using rabbit corneal stroma and three types of
cultured corneal cells both in vivo and in vitro. The three types of cultured rabbit corneal cells were seeded onto ACMP
of each side at a cell density of 5.0×103 cells/mm2.
Results: The optical and mechanical properties of the ACMP were similar to the normal porcine cornea. The collagen
fiber interconnected to the network, formed regular collagen bundles of the ACMP, and was parallel to the corneal surface.
The ACMP was transferred to the rabbit cornea stroma, which showed an intact epithelium and keratocytes in the implant
region. There were no inflamed cells or new vessel invasion one month after transplantation. The three types of cultured
rabbit corneal cells were positive for K3, vimentin, and aquaporin A. CFE and BrdU (5-bromo-2′-deoxyuridine) staining
showed no statistical difference. The cultured rabbit corneal limbal epithelial cells, keratocyte cells, and endothelial cells
formed a confluent cell sheet on the ACMP, which consisted of one to two cell layers. Immunofluorescence and scanning
electron microscopy examination showed that the cells steadily adhered to the surface of the ACMP and maintained their
conformation and special molecule expression such as K3, vimentin, and aquaporin A. Rabbit corneal epithelium-ACMP,
keratocytes-ACMP, and endothelium-ACMP scaffold was built in vitro.
Conclusions: The rabbit corneal scaffold was made by the ACMP as a frame with three types of allogeneic rabbit corneal
cells. This is a new concept in treating injured corneas.
The cornea is an avascular tissue that comprises one-sixth
of the anterior surface of the eye and provides 75% of the
refractive power needed for focusing light onto the retina.
Injury to the cornea can lead to corneal opacification, visual
impairment,  and  even  blindness.  At  present,  the  only
therapeutic option for dealing with such injury is corneal
transplantation.  This  is  the  most  successful  tissue
transplantation  procedure  in  humans  [1,2].  However,  one
limitation of this is its dependence on corneal availability from
healthy donors. Recently, the situation has been aggravated in
most regions of the world because the supply of donor tissue
barely  meets  the  ever-increasing  demand.  Therefore,  an
attractive alternative for dealing with the allograft shortage is
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to develop a corneal equivalent to restore the corneal function
necessary for normal vision [3].
Xenografts promise sufficient resources of organs for
clinical transplantation. The absence of blood vessels and the
intracorneal production of immunosuppressive factors appear
to  allow  corneal  allografts  to  survive.  However,  the
characteristic of “immunological privilege,” which makes the
immune system ignorant of the presence of a graft, is not
absolute  in  the  xenograft.  Evidence  suggests  that  corneal
xenografts ordinarily suffer severe rejection that is mostly
mediated  by  reactive  T-cells  and  antigen-presenting  cells
[4-6]. Recently, tissue engineering of the cornea has been
presented  as  a  promising  concept  in  overcoming  the
limitations  of  corneal  replacement  with  allografts.  The
principle of this type of tissue engineering is to create new,
functional autologous tissues, which have the potential for
regeneration and growth. The choice of an appropriate matrix
for constructing tissue engineered cornea is crucial [7]. The
ideal matrix should fulfill several requirements. It should be
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2180biocompatible  and  should  allow  for  epithelization  and
repopulation  with  autologous  recipient  interstitial  cells.
Various  types  of  matrices  such  as  polymer  or  fibrin-gel
scaffolds have been investigated [8]. Compared with these
matrices, the porcine cornea appears particularly attractive
because of its anatomic similarity to the human cornea [9].
Cell components of the cornea are the source of the antigens
of  the  major  histocompatibility  complex  responsible  for
allograft/xenograft rejection in various tissues. One way to
overcome  this  might  be  the  transplantation  of  corneal
substrates  without  their  cellular  components.  The  special
immunological or unspecific inflammatory response of the
xenogeneic  matrix  is  thought  to  be  reduced  by  the
decellularization  procedure,  and  the  matrix  might
subsequently  be  repopulated  with  recipient  cells  after
implantation [10].
Recently, various decellularization procedures have been
used to eliminate cells and create a cell-free matrix [8,11].
However, from these data, we conclude that the different
decellularization  procedures  vary  considerably  in  their
efficacy  so  we  have  developed  a  protocol  for  this.  In
preclinical studies, porcine cornea is regularly used as an
animal model due to its relative similarity to the human cornea
[3] and its availability in great numbers from slaughterhouses.
For this reason, various physical properties of the porcine
cornea  have  been  investigated  using  calorimetry,
turbidimetry, tensile tests, and hydrothermal isometric tension
measurements. Corneas of pigs, mice, rabbits, sheep, cats,
dogs,  and  cows  were  quantitatively  analyzed  for  water
content,  hydroxyproline,  nucleic  acid,  total  sulfated
polyanion, chondroitin sulfate/dermatan sulfate, and keratan
sulfate. Several samples or pools of tissue from each species
were used. Water (% of wet weight), hydroxyproline (mg/g
dry weight), and chondroitin sulfate (mg/g of hydroxyproline)
contents  were  approximately  constant  across  the  species
except  for  mice.  The  keratan  sulfate  content  (mg/g  of
hydroxyproline) increased with corneal thickness whereas the
dermatan  sulfate  content  decreased.  A  simple  model  of
mammalian  corneal  stroma  has  been  tested  against
biochemical and ultrastructural measurements performed on
several species. Water content, collagen, and total sulfated
polyanion  were  constant.  The  biological  corneal  tissue
reconstructed in vitro possessed three layers, the epithelium,
the  scaffold,  and  the  endothelium.  Xenogeneic  corneal
acellular matrix provides an ideal surface for corneal epithelial
and endothelial cells’ adhesion and proliferation. Therefore,
it is desired to be used as a scaffold for the reconstruction of
the cornea in vitro [3,12,13].
Three different serial digestion methods were used to
produce  the  acellular  corneal  stroma  material.  The
biocompatibility of the materials was investigated by cell
seeding,  and  the  materials  were  implanted  into  the  rabbit
corneal stroma layer. The three cell types in the material were
completely decellularized, and the collagen or elastic fibers
were reserved integrally, showing a typical three-dimensional
network.  Rabbit  corneal  fibroblasts  could  expand  on  the
materials in vitro. No obvious rejection could be observed,
and the materials were gradually absorbed. Therefore, there
was decellularization of the porcine cornea. Moreover, the
rejection of the transplanted cornea is a common finding, and
the key factor driving this immune rejection is known to be
corneal  endothelial  damage.  The  results  regarding  the
successful application of corneal allotransplantation suggest
that the construction of the tissue engineered cornea with
allogeneic epithelial cells, keratocytes, and endothelial cells
has therapeutic potential. Thus, in this study, an active corneal
epithelial,  stromal,  and  endothelial  equivalent  has  been
reconstructed  using  porcine  decellularized  stroma
components. The xenogeneic epithelial cells, keratocytes, and
endothelial cells were then evaluated [13].
METHODS
Animals:  Fifteen  New  Zealand  white  rabbits  (Peking
University Health Science Center, Beijing, China) weighing
1.5–2.0  kg  were  used  in  this  study.  This  research  was
performed under the guidelines of ARVO (Association for
Research in Vision and Ophthalmology) and their statements
for the use of animals in ophthalmic and vision research guides
[14].
Acellular porcine corneal matrix: Fresh porcine corneas were
obtained  from  a  local  slaughterhouse.  First,  the  corneal
epithelium and endothelium were removed. This was done
using 1.2 U/ml dispase II (Roche Applied Science, Penzbeg,
Germany) at 4 °C for 16 h. The stroma was then trimmed to
a 10 mm diameter section. To remove the hereditary material,
the stromal discs were soaked in 1 mM Tris-HCl for 12 h,
treated with a 1% Triton X-100 solution (Sigma, St. Louis,
MO) at 4 °C for 12 h, digested with 0.25% trypsin-EDTA
(Gibco-BRL  Life  Technologies,  Gibco,  Carlsbad,  CA)  at
37 °C for 30 min, and treated with DNase (Sigma) and RNase
(Sigma) at 4 °C for 16 h. Between the treatment steps, the discs
were washed twice with 5 mM Tris-HCl for 10 min. Finally,
the scaffold materials were freeze-dried at −20 °C for 8 h, 0 °C
for 8 h, and 20 °C for 4 h and then sterilized with gamma
irradiation [15-18].
Physical  and  mechanical  characterizations  of  porcine
acellular corneal matrix:
Optical property—The primary acellular corneal matrix
of porcine (ACMP) was placed on 35 mm culture dishes, and
glycerol (90%) was added. They were dehydrated for 2 h and
4  h  at  room  temperature.  The  light  transparence  and
absorption  were  measured  using  a  spectral  photometer
(DR5000; Hach, Loveland, CA). The primary cornea and the
dehydrated ACMP were measured at 2 h and 4 h and compared
to normal porcine cornea [3,19].
Mechanical properties—After sterilization by gamma
irradiation,  the  dehydrated  ACMP  was  tested  strength,
expansion,  and  water  content.  The  rate  of  strength  was
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Aikoh, Tokyo, Japan) to elongate the dehydrated ACMP. The
initial length (L1) and area (A1) of the normal porcine cornea
and primary ACMP and the final length (L2) and area (A2) of
the normal porcine cornea and the dehydrated ACMP were
measured.  The  rate  of  strength  was  measured  using  the
following formula:
                                       (L2-L1)/(A2-A1)
The rate of water content was investigated using an electronic
scale  (AG135;  Mettler  Toledo,  Schwerzenbanch,
Switzerland) by the following formula:
                                       (G2-G1)/G2 x 100%
where G1 is the weight of the primary condition of ACMP or
the normal porcine cornea and G2 is the weight after being
dried for 2 h at 65 °C.
The rate of expansion was measured using a counting cup
(VC305;  Branluebbe,  Norderstedt,  Germany)  with  the
following equation:
                                       (V1-V)/V1 x 100%
where V is the volume after dehydration for 2 h at 65 °C, V1
is the volume of the primary condition of the normal porcine
cornea and ACMP. The overall experimental sizes of the
specimens were 1 cm×1 cm [3,20,21].
Cell  culture:  The  New  Zealand  white  rabbits  were
anesthetized with an intramuscular injection of 30 mg/kg of
ketamine (Huawei, Shanghai. China) and 5 mg/kg of xylazine
(Huawei).  Local  anesthetic  was  added  with  0.5%
proparacaine hydrochloride (Alcon, Fort Worth, TX). The
limbal explants were dissected from the limbal zone, and the
stromal explant was dissected from the stromal layer. Their
sizes were 2.0 mm in width, 2.0 mm in length, and 200 µm in
thickness.  The  endothelial  cell  sheets  were  peeled  with
Descemet  membrane  from  the  stromal  layer.  The  limbal
explants, stromal explants, and endothelial cell sheets were
rinsed three times with Dulbecco’s phosphate buffered saline
(D-PBS; with 100 IU/ml penicillin and 25µg/ml gentamicin;
Sigma). Then, they were treated with 1.2 U/ml dispase II
(Boehringer Mannheim) for 30 min at 37 °C in an incubator
with  a  humidified  atmosphere  of  5%  CO2.  The  three
specimens were washed three times with Dulbecco’s modified
Eagle’s medium (DMEM; with 10% fetal bovine serum) and
placed directly onto 35 mm culture dishes. The side of the
limbal explant epithelial cells and endothelial cell sheets were
forward up and dried naturally for 15 min on a clean bench to
adhere to the culture dishes. A 10% DMEM culture medium
was added and was changed every three days. The corneal
epithelial  cells,  keratocytes,  and  endothelial  cells  were
culturally adhered to the culture dishes. To make single cell
suspension, these were then treated with 0.25% trypsin-EDTA
(Gibco-BRL)  in  an  incubator  for  10  min  at  37  °C  and  a
humidified atmosphere of 5% CO2. These three different cell
types were directly seeded onto the epithelial, stromal, and
endothelial  sides  of  the  ACMPs  at  1×104  cells/cm2  cell
density. Submerged culture was two weeks, and airlifting
culture was two weeks. The culture medium was changed
every  three  days.  The  composition  culture  media  was  as
follows: 3:1 DMEM/F12, 10% fetal bovine serum (Gibco-
BRL), 1% penicillin-streptomycin, 10 ng/ml epithelial growth
factor (EGF; Gibco-BRL), 5 µg/ml insulin (Gibco-BRL), 10
nM cholera toxin (Sigma), 5 µg/ml transferrin (Sigma), 4 ng/
ml hydrocortisone (Sigma), and 2×10−14 M 3,3′,5-triiodo-L-
thyronine (T3; Sigma) [22,23].
Colony  formation  efficiency  (CFE)—For  the  cell
growth assay, primary cultured rabbit corneal epithelial cells,
keratocytes, and endothelial cells were passed and seeded at
a density of 300 cells per dish onto 35 mm culture dishes
(Corning, Glendale, AZ). Cells were cultured with the culture
medium at 37 °C in an incubator with a humidified atmosphere
of 5% CO2. The culture medium was changed every three
days. Colonies were identified under an inverted microscope.
After 10 days, the cells were washed three times with D-PBS
and were fixed with 10% formalin for 30 min at 4 °C. The
cells  were  stained  in  2%  rhodamine  blue  (Merck,  Haar,
Germany) and 2% Nile blue (Merck) mixed solution (ratio
1:1) for 30 min at 4 °C. The formed colonies were counted,
and the colony formation efficiency (CFE) was identified
according to following equation [24]:
   CFE (%) = colony number/seeding cell number x 100%
BrdU (5-bromo-2′-deoxyuridine) incorporation and
proliferation  assay—The  primary  cultured  rabbit  corneal
epithelial cells, keratocytes, and endothelial cells were passed
and seeded at a density of 300 cells per dish onto 15 mm
culture plates (Corning). Cells were cultured at 37 °C in an
incubator with a humidified atmosphere of 5% CO2 for 30 min
with 10% FBS DMEM culture medium containing 10 µm
BrdU (Chemicon, Temecula, CA). After 30 min of incubation,
the medium was changed to a BrdU free medium and cultured
for 24 h. The cells were fixed in 70% ethanol for 30 min at
4 °C. The fixed cells were then treated for 30 min with an anti-
BrdU monoclonal antibody (Chemicon). BrdU was detected
by a FITC-conjugated secondary antibody (Chemicon). The
BrdU  positive  cells  were  detected  using  a  confocal  laser
microscope (Zeiss, Oberkochen, Germany) [25,26].
Biocompatibility tests in vivo and in vitro: The New Zealand
white rabbits, weighing approximately 2–3 kg, were studied
following the guidelines established in the ARVO statement
for the use of animals in ophthalmic and vision research. All
rabbits  were  anesthetized  by  intramuscular  injection  with
xylazine hydrochloride (10 mg/kg; Bayer, Munich, Germany)
and ketamine hydrochloride (60 mg/kg; Huawei). A lamellar
stromal pocket (size 6×6 mm) was performed in the center of
the right eye cornea. The ACMP was rinsed three times with
PBS  and  was  approximately  4×4  mm.  The  ACMP  was
inserted into the rabbit corneal stromal pocket and sutured
using  separate  radial  sutures  of  10–0  nylon.  After
transplantation,  the  rabbits  were  examined  daily  with  a
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2182penlight  to  check  for  graft  clarity  and  signs  of  wound
dehiscence, infection, or inflammation. After one, two, three,
and four weeks each, each transplanted eye was examined
using slit-lamp microscopy and photographed for changes in
transparency and neovascularization. At specific time points
the  rabbit  corneas  were  harvested  under  anesthesia.  The
primary  cultured  rabbit  corneal  limbal  epithelial  cells,
keratocytes, and endothelial cells were passaged and seeded
onto the epithelial side, keratocyte side, and endothelial side
of the ACMP at a cell density of 5.0×103 cells/mm2. After
waiting 30 min for the seeded cells to adhere to the ACMP on
each side, the culture medium was added and was cultured at
37 °C in a humidified atmosphere of 5% CO2 for four weeks.
The culture medium was changed every three days [27-29].
Scanning  electron  microscopy:  For  scanning  electron
microscopy (SEM), the ACMP and specimens of the three
types  of  cell  seeded  ACMP  were  fixed  with  2%
glutaraldehyde in 0.1 M PBS (pH 7.2) at 37 °C for 1 h, washed
three times in buffer for 10 min, fixed in 1% osmium tetroxide
for 1 h at 37 °C, and dehydrated through a graded series of
ethanol. Three types of fixed cell seeded ACMP specimens
were critical point dried (HCP-2; Hitachi, Ibaraki, Japan),
coated  with  platinum  using  an  Ion  Coater  (IB-5;  EIKO,
Ibaraki,  Japan),  and  observed  on  a  scanning  electron
microscopy  (Hitachi  S-800;  Hitachi)  at  magnifications
between 500X and 2000X [30].
Immunofluorescence: Immunofluorescence staining was used
to detect keratin 3, vimentin, and aquaporin A for the cultured
rabbit corneal epithelial cells, keratocytes, and endothelial
cells. The three types of passaged rabbit corneal cells were
fixed in ice-cold methanol on a culture plate for 10 min and
washed  in  PBS.  The  ACMP  and  cell-ACMP  scaffold
specimens  were  freshly  frozen  in  an  optimal  cutting
temperature (OCT; Sakura Finetek, Torrance, CA) compound
and then sliced with a cryostat. Section tissues were air dried.
The sections of the three types of cultured cells were blocked
with 2% BSA in PBS, and primary antibodies and 1:100
diluted  fluorescein  conjugated-goat  and  anti-mouse  IgG
secondary  antibodies  were  applied  overnight  in  a  moist
chamber set at 4 °C. The primary antibodies were anti-keratin
3 (1:100; Chemicon), anti-vimentin (1:100; Sigma), and anti-
aquaporin A (1:100; Chemicon). The negative controls were
prepared by incubation with the secondary antibody alone. All
cells and tissues were observed on a confocal laser microscope
(LSM 510; Zeiss) [31,32].
Figure 1. Optical properties of the ACMP. The visually opaque initial ACMP (A) was dehydrated by 90% glycerol for 2 h to obtain a
transparency similar to a normal porcine cornea. The initial ACMP was visually opaque (B). Normal porcine cornea was transparent (C).
TABLE 1. PHYSICAL AND MECHANICAL CHARACTERIZATION OF PORCINE ACELLULAR CORNEAL MATRIX.
                                      ACMP                               ACMP                                     ACMP                                  Normal
Contents                       (initial)                      (dehydrated 2 h)                    (dehydrated 4 h)                     porcine cornea
Strength 3.07±0.62 3.34±0.84 3.39±0.23 3.51±0.64
Expansion 88.57±1.24 75.25±0.93 71.87±1.31 73.01±0.54
Ratio of water
content
89.35±0.61 74.62±0.54 65.17±0.21 71.93±0.47
Ratio of light
transparency
1.8±0.06 44.11±0.37 48.66±0.28 54.77±0.43
Comparison in terms of strength, expansion, and ratio of water content in initial ACMP, dehydrated ACMP and normal porcine
cornea,  showed no statistical significance of the differences (p>0.05) while the ratio of light transparency of initial ACMP
compared to other groups showed a statistical significance of the difference (p<0.05). Statistical significance was assigned when
the p value was less 0.05.
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passaged cell types were cultured to adhere to the culture plate
and harvested for western blot analysis. The three harvested
type cells were sonicated for 15 s intervals at 100 W. Cell
debris was cleared from the lysates by centrifugation at 200x
g for 15 min at 4 °C. Lysate fractions were separated into
soluble and particulate using centrifugation at 29,000x g for
30  min  at  4  °C.  In  some  experiments,  the  cells  were
fractionated by low-speed centrifugation at 1000x g and high-
speed centrifugation at 1,000,000x g for 15 min at 4 °C. The
pellets  were  resuspended  in  modified  radio
immunoprecipitation assay (RIPA) buffer (50 mM Tris-HCI,
pH  7.4),  1%  Nonidet  p-40,  0.25%  sodium  deoxycholate,
150  mM  sodium  chloride,  1  mM  EDTA,  1  mM
phenylmethanesulfonyl fluoride (PMSF), 5 µg/ml aprotinin,
5 µg/ml leupeptin, 1 µg/ml pepstatin, 1 mM Na3VO4, and 1
mM sodium fluoride. Protein concentrations were determined
with the bicinchoninic (BCA) protein assay reagent kit (Pierce
Biotechnology,  Rockford,  IL).  Both  the  supernatant  and
particulate fractions were stored at −80 °C. Sodium dodecyl
sulfate-PAGE  (SDS–PAGE)  was  performed  on  Bis-Tris
4%-12% gels (NuPAGE; Novex, San Diego, CA) with MES
(2-N-morpholino-ethanesulfonic  acid)  running  buffer
(Invitrogen, Carlsbad, CA). Proteins were detected on the
immunoblots  by  chemiluminescence  (SuperSignal  Femto
West Chemiluminescent Substrate Kit; Pierce) according to
the manufacturer’s directions. Blots were developed on an
autoradiograph film (CL-Xposure; Pierce and GBX developer
and fixer solutions, Eastman Kodak, Rochester). Blots were
reused after the antibodies, and substrates were removed with
the western blot stripping buffer (Restore; Pierce) according
to the manufacturer’s directions. Antibodies used in these
studies  included  anti-keratin  3,  anti-vimentin,  and  anti-
aquaporin A [32].
Statistics: Statistical analyses were performed using SPSS for
Window, Version 11.0 (SPSS Inc., Chicago, IL). Statistical
significance was set at p<0.05.
Figure 2. Histological characteristics of
the  ACMP.  HE  stained  histological
sections  showed  that  the  major
immunogenic porcine corneal epithelial
cells, keratocytes, and endothelial cells
were completely removed in (A; 10X)
and  (B;  40X).  The  epithelial  cells,
keratocytes, and endothelial cells would
be detected on each layer of a normal
porcine cornea (C; 10X) and (D; 40X).
SEM images of the ACMP showed that
the  collagen  fibers  and  fibers  inter-
connecting  to  network  had  formed
collagen  bundles,  which  were  regular
and parallel to the corneal surface (E;
5,000X) and (F; 20,000X). These were
similar  to  the  normal  porcine  cornea
matrix.
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Physical  and  mechanical  characterization  of  porcine
acellular corneal matrix: Visually, the initial ACMP was
opaque.  After  dehydration,  the  ACMP  cleared  with  a
transparency similar to a normal porcine cornea (Figure 1).
The  properties  of  the  rate  of  strength,  expansion,  water
content, and light transparency of the ACMP and normal
porcine cornea are shown on Table 1.
Histological characterization of acellular corneal matrix of
porcine: The histological characteristics of the ACMP were
shown  from  the  hematoxylin  and  eosin  (HE)  stain  and
scanning  electron  microscopy.  The  major  immunogenic
porcine corneal epithelial cells, keratocytes, and endothelial
cells  were  completely  removed  by  a  series  of  extraction
procedures, and the matrix architecture was well preserved
compared with that of the normal porcine cornea (Figure 2A-
D). Figure 2E,F show that the collagen fiber diameter and the
fiber interconnected to the network formed collagen bundles
both regular and parallel to the corneal surface. These were
similar to the normal porcine cornea matrix.
Biocompatibility tests of porcine acellular corneal matrix:
Implantation  and  clinical  evaluation—Slit  lamp
examination was performed one, two, three, and four weeks
after  surgery  on  eight  rabbit  right  eyes  and  showed
reepithelialization within the first week. Although a mild haze
was initially observed, none of the ACMP implants showed
any inflammation or rejection signs over this period. In the
rabbit series, the epithelium was beginning to heal one week
after surgery (Figure 3B). One month after surgery, rabbit
cornea sections showed a stratified epithelium, and stromal
cells had migrated into the implant region according to HE
staining (Figure 3D,E). Compared to the normal rabbit cornea
(Figure 3F), the ACMP implanted rabbit cornea showed a
similar normal rabbit stromal histological appearance, and the
implants were well integrated within the host after one month
of surgery. None of the implants showed any inflammation
cells or neovascular invasion in the corneas over this period.
In vitro performance—To examine the compatibility of
the ACMP with the cultured rabbit corneal limbal epithelial
cells,  keratocytes,  and  endothelial  cells,  the  three  rabbit
corneal cell types were separated from the special corneal
tissues and were cultured in vitro. As Figure 4A-C shows,
three cell types were moved from the tissues and were grown
on the culture plates. The proliferations of these three cell
types were tested by colony formation efficiency and BrdU
proliferation assay. After 10 days in culture, the three cell
types had good growth and formed large colonies. The colony
formation efficiency was 23.16±3.61% for limbal epithelial
cells,  18.16±3.12%  for  keratocytes,  and  11.72±1.42%  for
endothelial cells (p<0.05). Counting the continuously cultured
corneal limbal epithelial cells, keratocytes, and endothelial
cells, which one set was stained with BrdU for three days and
another stained for seven days, the BrdU staining indexes
were 13.8%, 21.3%, and 17.2% after three days and 42.2%,
51.5%, and 48.1% after seven days, respectively (p<0.05).
The expressions of the marker proteins were examined by
Figure 3. Investigate the biocompatibility of ACMP for rabbit cornea. The ACMP was inserted into a rabbit corneal stromal pocket and
observed over one month of post surgical period. The cornea showed a mild haze at one day (A), optically clear slit lamp images at one week
(B) and one month (C) and no inflammation or rejection signs in (D; 10X) and (E; 20X). The normal cornea is presented in (F) as a control
(10X).
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in the cultured corneal limbal epithelial cells while vimentin
expression was highest in the keratocytes. Aquaporin A was
only detected in the slender band in the endothelium, and the
bands  were  thick.  The  passaged  rabbit  corneal  limbal
epithelial cells, keratocytes, and endothelial cells formed a
confluent cell sheet on the ACMP, consisting of one or two
cell layers. No changes in cell properties or in morphological
characteristics were observed. The three cell types maintained
their shape and specific molecule expression in cell-ACMP
scaffolds such as keratin 3, vimentin, and aquaporin A (Figure
5D-F), which was the same as the three cultured cell types
(Figure 5A-C). SEM examination results showed that the cells
steadily adhered to the surface of the ACMP and maintained
their conformation (Figure 5G-H).
DISCUSSION
The  replacement  of  diseased  tissues  and  organs  with
bioengineered tissue is rapidly moving from the realm of
science  fiction  to  reality.  Elegant  and  innovative  work  in
laboratories around the world has demonstrated the feasibility
of  similar  approaches  for  bioengineering  corneal
replacements [2,3,6]. Successful tissue engineering is known
to depend on the provision of a promising scaffold during the
initial stages of reconstruction [33,34]. This is necessary so
that the cells in an implant can proliferate, move out onto a
framework, and lay down extracellular matrix. At present,
synthetic and natural biological materials are used to provide
scaffolding support for tissue engineering, and compared with
synthetic  biomaterials,  natural  biomaterials  are  more
promising because of their flexibility and suitable physical
and  mechanical  properties.  Moreover,  many  biomaterials
demonstrate  physiologic  and  biochemical  functions
equivalent to the normal cornea, but each has a limitation
preventing its current use in humans [3,14,35]. Many corneal
wounds and scarring diseases persist for weeks and months or
else recur frequently and even progress to corneal perforation.
Our major aim in developing an artificial epithelium scaffold,
stroma  scaffold,  and  endothelium  scaffold  by  tissue
engineering is to provide a cure for those individuals afflicted
with  severe  corneal  wounds  associated  with  a  deeper
involvement  of  the  epithelial  basement  membrane  and  of
stromal lamella or endothelium [20,36].
Multilayered cultured corneal cells can be generated by
using tissue culture techniques, and these limbal epithelial,
keratocytes, and endothelial cell sheets have been successfully
grafted to damaged eyes. However, the fragility of these grafts
by lacking a scaffold makes them difficult to handle and
subject to easy shearing from the recipient eye. Thus, analogue
of  engineering  tissue  is  to  contain  a  compatible  scaffold
component. The amniotic membrane is the logical choice as
a source of the biomaterials in corneal transplantation [8,11,
37]. However, its use greatly limits the characteristics of the
membrane. Our approach in tissue engineering the corneal
epithelial scaffold, stroma scaffold, and endothelial scaffold
is based on the porcine acellular matrix. This is intuitively
attractive because of its anatomic similarity to the normal
corneal stroma, and biocompatibility tests have shown that the
ACMP is an ideal biomaterial because limbal epithelial cells,
keratocytes,  and  endothelial  cells  can  fill  the  surface  and
produce extracellular matrix. In this study, we have tested the
efficiency  of  a  tissue  engineered  ACMP.  Our  findings
demonstrate that ACMP is a suitable biocompatible material
on which epithelial cells, keratocytes, and endothelial cells
Figure 4. Phase appearance and marker
protein expression of cultivated corneal
limbal epithelial cells, keratocytes, and
endothelial  cells.  The  rabbit  corneal
limbal epithelial cells (A), keratocytes
(B),  and  endothelial  cells  (C)  were
cultivated for one week to confluence on
culture  dishes,  primary  (10X).  The
protein  of  keratin  3  was  specially
expressed  in  the  cultivated  corneal
limbal  epithelial  cells  while  vimentin
expression  was  highest  in  the
keratocytes.  Aquaporin  A  was  only
detected in the endothelium (D).
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2186may attach and proliferate in vitro. Although our experiment
is not adequate for clinical use on humans [38,39], proper
biocompatibility  and  the  basic  requirement  for  the  tissue
engineered  cornea  has  subsequently  been  confirmed  by
histology.  The  ACMP  gradually  degrade  and  become
absorbed, accompanied by an in growth of new tissue. The
tissue  engineering  of  corneal  scaffolds  results  in  the
fabrication of a useful corneal lamella equivalent with respect
to gross appearance, optical clarity, and histological structure.
The maintenance of corneal transparency is dependent
upon the integrity of its three distinct layers, the epithelium,
stroma,  and  endothelium.  All  these  layers  are  essential
because they elicit the outward transport of net ions from the
stroma and provide the driving force for fluid transport into
tears and the anterior chamber. In detail, a major function of
the corneal endothelium is to maintain corneal transparency
by  regulating  corneal  hydration.  Proteoglycans  associated
with stromal collagens bind water and produce a pressure
gradient  across  the  endothelium.  This  is  indicated  by  our
finding that tissue engineered construct transplantation does
not cause the cornea to become translucent immediately. This
is because transparency of the cornea is maintained by tight
junctions in the epithelium that control the flow of fluid into
the  eye.  Intact  epithelial  and  endothelial  cells  of  the
regenerative corneal tissue suggest that our corneal product is
likely help to treat some corneal diseases. Furthermore, the
cornea is one of the most densely innervated tissues in the
body and is richly supplied by sensory and autonomic nerve
fibers. Nerve bundles enter the cornea at the periphery in a
radial fashion parallel to the corneal surface [6,9,10,40].
Therefore, in our experiments, tissue engineered corneal
epithelial, stromal, and endothelial scaffolds may act as a
physiologically functional tissue substitute and not simply as
a prosthetic device. Tissue engineered tissue replacements
Figure 5. Rabbit corneal epithelium-ACMP, keratocyte-ACMP, and endothelium-ACMP scaffold was built in vitro. The cultivated rabbit
corneal epithelial cells, keratocytes, and endothelial cells were positive for keratin 3, vimentin, and aquaporin A following immunofluorescence
staining (A, B, and C, respectively) and these three types of cultivated cells were seeded onto ACMP. The epithelium-ACMP, keratocyte-
ACMP, and endothelium-ACMP scaffold were built, respectively (D, E, and F). SEM showed that these three types of cultivated cells adhered
to the surface of ACMP, and maintained their conformation (G, H, and I).
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2187may represent the future for the repair of many tissues and
organs. For the cornea, we are closer to the realization of this
prospect than for other tissues. Our study demonstrates that
the  tissue  engineered  corneal  epithelial,  stromal,  and
endothelial  scaffolds  were  constructed  with  ACMP  and
cultured limbal epithelial cells, keratocytes, and endothelial
cells in vitro [41,42]. In summary, transplantations with three
types  of  tissue  engineered  corneal  scaffolds  may  be  an
effective and safe treatment to facilitate the rapid restoration
of  the  cornea  without  causing  complications.  Although
progress  has  been  achieved,  tissue  engineered  corneal
replacements can be easily produced and transplanted. Our
laboratory and many others will continue to pursue this goal
of readily available corneal replacements.
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